- VTE is preventable. Effective prophylaxis reduces VTE incidence by 60 percent.
- VTE is common, with at least 900,000 cases annually in the U.S. during or post-hospitalization. An additional 1 million estimated VTEs are not related to hospitalization.
- VTE is deadly. At least one-third of patients with VTE die as a result of it.
- VTE causes long-term morbidity.
- VTE is recurrent in 40 percent of patients.
- Each VTE incidence costs between $10,000 and $20,000, according to the Agency for Health care Research and Quality.
Home > Center for Innovation in Quality Patient Care > Areas of Expertise > Eliminating Infections and Complications > DVT
Why is DVT/VTE important?
We’ve Changed Our Name
The Center for Innovation is now part of the new Armstrong Institute for Patient Safety and Quality. Learn more.
Upcoming Courses
June 18-22
Lean Sigma Green Belt Program
July 10-11
Lean for Healthcare
September 17-19
Patient Safety Practitioner Program
September 18-19
Lean for Healthcare
October 15-16
CUSP Workshop
Connect with Johns Hopkins Medicine
Facebook
Twitter
Sharecare
Blogs
YouTubeSubscribe to Johns Hopkins Medicine News
RSS
Podcasts
